期刊文献+

68例胃肠间质瘤临床病理及预后分析 被引量:4

Clinical and prognostic analysis of gastro-intestinal stromal tumors
暂未订购
导出
摘要 目的:分析胃肠间质瘤(gastrointestinal stromal tumors,GISTs)临床病理特性及影响预后因素,探讨提高GISTs疗效的有效方法。方法:对随访的68例GISTs患者的临床资料行Kaplan-Meier生存分析。结果:生存分析显示肿瘤直径<5cm、病理核分裂像<5/50HPF、服用格列卫的患者生存率较高,手术治疗行肿瘤完整切除术与扩大切除术生存率差异无统计学意义(P=0.8705)。结论:肿瘤直径、核分裂像与预后有关,完整切除肿瘤可获得根治效果,术后服用格列卫能改善患者预后。 Objective: To investigate the clinical features and prognosis of gastrointestinal stromal tumors (GISTs). Methods: Sixty-eight cases of GISTs patients were analyzed retrospectively. There were 39 male and 29 female patients in 68 cases who presented a mean age of 54.8 years. The main complaints were abdominal pain (40%), distention (34%) and mass (30%). Fifty-eight patients received enbloc resection, while extended removal was carried on others. Fifty-five tumors located in ga^strointestinal duct. Results: Tumor diameters of 36 cases were more than 5 centimeters. Routine pathologic test found spindle tumor cells and karyokinesis cells more than 5/50 HPF in 29 samples. There was 1 patient with lymph node metastasis. The positive rates of immunohistochemical staining of CD117, CD34 and CSMA were 90%, 69% and 30%, respectively.Glivec was given to 46 patients (400 mg/d) for one year at least. Recurrence diseases were found in 12 cases who did not receive Glivec treatment. The survival rates of 3 year and 5 year were 82.3% and 22.1% (15/68). No difference was found between en bloc resection and extended removal group (P=0.870 5). Conclusion: The positive staining of CD117 was an important symbol of GISTs, en bloc resection was proved to be an ideal surgical procedure.
出处 《中国现代普通外科进展》 CAS 2007年第5期409-411,共3页 Chinese Journal of Current Advances in General Surgery
关键词 胃肠间质瘤·预后·治疗 Gastrointestinal stromal tumors·Prognosis·Surgical resection
  • 相关文献

参考文献6

  • 1Kim HJ, Lim SJ, Park K, et al. Multiple gastrointestinal stromal tumors with a germline C-KIT mutation [J]. Pathol Int, 2005,55 (10): 655-659.
  • 2Blanke C, Eisenberg BL, Heinrich M. Epidemiology of GIST[J]. Am J Gastroenterol, 2005,100 ( 10) :2366-2374.
  • 3Sanborn RE, Blanke CD. Gastrointestinal stromal tumors and the evolution of targeted therapy[J]. Clin Adv Hematol Oncol, 2005,3 (8): 647-657.
  • 4Gomandone A, Boglione A. Biology, diagnosis and therapeutic options in gastrointestinal stromal tumours [J]. Minerva Chir, 2005,60 (5):197-203.
  • 5Haller F, Gunawan B, von Heydebreck A, et al. Prognostic role of E2F1 and members of the CDKN2A network in gastrointestinal stromal tumors[J]. Clin Cancer Res, 2005,11 ( 18):6589-6597.
  • 6Yang DM, Kim H, Kang JH, et al. Computed tomogaphy and sonographic findings of hepatic metastases from gastrointestinal stromal tumors after chemotherapy [J]. J Comput Assist Tomogr, 2005,29 (5): 592-595.

同被引文献17

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部